Ocugen Stock (NASDAQ: OCGN) stock price, news, charts, stock research, profile.
Open | $1.750 |
Close | $1.640 |
Volume / Avg. | 9.169M / 7.776M |
Day Range | 1.570 - 1.760 |
52 Wk Range | 0.345 - 2.105 |
Market Cap | $423.152M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 70 |
Short Interest | 12.32% |
Days to Cover | 9.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocugen (NASDAQ: OCGN) through any online brokerage.
Other companies in Ocugen’s space includes: Renovaro (NASDAQ:RENB), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Inozyme Pharma (NASDAQ:INZY) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for Ocugen (NASDAQ: OCGN) was reported by HC Wainwright & Co. on Thursday, February 22, 2024. The analyst firm set a price target for 7.00 expecting OCGN to rise to within 12 months (a possible 324.32% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Ocugen (NASDAQ: OCGN) is $1.6497 last updated March 28, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Ocugen.
Ocugen’s Q4 earnings are confirmed for Friday, February 24, 2023.
There is no upcoming split for Ocugen.
Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.